Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan · Delayed Price · Currency is TWD 81.20
-4.40 (-5.14%)
At close: Mar 27, 2026
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 126.1 billion as of March 27, 2026. Its market cap has decreased by -11.85% in one year.
Market Cap
126.10B
Enterprise Value
121.24B
Revenue
38.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
81.20
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 126.10B, an increase of 1,484.51%. That is a compound annual growth rate of 133.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 126.10B | -47.51% |
| Dec 31, 2025 | 240.25B | 154.60% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
| Dec 26, 2022 | 7.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pell Bio-Med Technology | 36.61B |
| Lin BioScience | 31.56B |
| Lumosa Therapeutics | 25.21B |
| Oneness Biotech | 24.93B |
| Sunmax Biotechnology | 21.19B |
| AP Biosciences | 18.14B |
| EirGenix | 17.22B |
| Medigen Vaccine Biologics | 17.09B |